These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6802879)

  • 21. Projected estimation of factor VIII requirements for home treatment based on a pilot study of two haemophilic patients.
    Davies SH
    Scand J Haematol Suppl; 1977; 30():87-9. PubMed ID: 267310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the character of Factor VIII inhibitors following Factor VIII transfusion.
    Ghosh S; Rizza CR
    Scand J Haematol; 1984 Sep; 33(3):239-43. PubMed ID: 6438792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pre-transfusion assay of cryoprecipitate.
    Thomson S; Meek PA
    Can J Med Technol; 1971 Oct; 33(5):208-11. PubMed ID: 5124921
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of factors VIII:C and VIIIR:Ag in the detection of classic hemophilia. Study of 40 cases].
    Ambríz-Fernández R; Reyna-Fregoso MP; Cruz ML; Avilés A; García MA; Morales MR; Pizzuto J
    Rev Invest Clin; 1984; 36(3):257-63. PubMed ID: 6440253
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose requirement for replacement therapy in hemophilia A.
    Allain JP
    Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of an animal model to evaluate hemophilia therapies.
    Giles AR
    Prog Clin Biol Res; 1984; 150():265-76. PubMed ID: 6431432
    [No Abstract]   [Full Text] [Related]  

  • 28. [Factor 8, its preservation in the blood, plasma, fraction I of plasma, its fate in a transfused hemophiliac].
    Revol L; Belleville J; Thouverez JP; Denhaut MG
    Bibl Haematol; 1965; 23():1200-9. PubMed ID: 5885205
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfusion in hemophilia.
    van Creveld S
    Bibl Haematol; 1970; 34():1-8. PubMed ID: 4908198
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of hemophilia and its social aspects].
    Digilio G
    Minerva Pediatr; 1967 Nov; 19(44):1963-9. PubMed ID: 5616636
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological control of substitution therapy in hemophilia A].
    Lisichkov T
    Vutr Boles; 1972; 11(5):103-7. PubMed ID: 4680013
    [No Abstract]   [Full Text] [Related]  

  • 33. The suppression of factor VIII antibodies in haemophilia.
    Dormandy KM; Sultan Y
    Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of factor VIII and screening of factor VIII related diseases].
    Hashimoto S
    Nihon Rinsho; 1981; 39(12):3728-36. PubMed ID: 6803036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemophilia as a medical and social problem].
    Nosotti NM
    Minerva Med; 1972 Dec; 63(86):4677-9. PubMed ID: 4642650
    [No Abstract]   [Full Text] [Related]  

  • 36. Absorption of factor VIII by aluminium hydroxide.
    Seghatchian MJ; Kemball-Cook G; Barrowcliffe TW
    Haemostasis; 1979; 8(2):106-16. PubMed ID: 499928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor development in haemophiliacs: theoretical background and clinical aspects.
    Sultan Y
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S55-7. PubMed ID: 7495970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.
    Hsu HC; Chen YF; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):450-4. PubMed ID: 10418180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.